Loading...
Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature review
Blau syndrome (BS) is an autoinflammatory disorder characterized by non-caseating granulomatous dermatitis, arthritis, and uveitis. We present a case of refractory and severe BS that was treated with the Janus kinase inhibitors (JAKINIBS), Tofacitinib (TOFA) and then Baricitinib (BARI). Our aim was...
Na minha lista:
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
SAGE Publishing
2022-04-01
|
Serier: | Therapeutic Advances in Musculoskeletal Disease |
Online adgang: | https://doi.org/10.1177/1759720X221093211 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|